Hypertrophic Cardiomyopathy for Professionals


Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder defined by left ventricular (LV) hypertrophy that cannot be explained by another cardiac or systemic disease. Learning more about HCM will ensure you are better able to discuss its impact with your patients.

Patients whose lives have been restricted by HCM may be able to reduce symptoms and comorbidities. Watch this video series to increase your knowledge.

From diagnosis to management and beyond, these HCM podcasts will help you communicate best with your patients.

The Guidelines-on-the-Go App features the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy, plus so much more.

What’s New When It Comes to Diagnosing and Treating Hypertrophic Cardiomyopathy Patients

Watch this video to find out from leading experts as they discuss the impact of the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy. Learn the latest on diagnostic and treatment options for patients, including new treatments on the horizon. Advance a new standard of care for patients with HCM. 

HCM Patients

In speaking with patients who complain of symptoms consistent with HCM, ask if family members have been diagnosed with HCM, or if there is a family history of sudden cardiac arrest or died due to an unknown cardiovascular disease. When patients present with symptoms such as fatigue, fainting, shortness of breath, chest pain or heart palpitations without a known cause, suspect and test for HCM. With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities.

wife straightening her husband's tie

A thumbnail image of the Hypertrophic Cardiomyopathy infographic in collaboration with HCMADownload this free poster developed in collaboration with HCMA

Print this poster as a discussion guide for conversations with patients. As you talk with your patients use this as an educational tool. Early detection and disease/symptom management may help reduce some of the consequences of HCM and improve outcomes.

With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities.

Hypertrophic Cardiomyopathy - Sudden Cardiac Death Risk Calculator

illustration
This calculator is for use in calculating risk of sudden cardiac death in patients with HCM using the 2020 AHA/ACC Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy.

American Heart Association's Hypertrophic Cardiomyopathy Initiative is sponsored by Bristol Myers Squibb.